...
首页> 外文期刊>MBio >Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive Mycobacterium tuberculosis
【24h】

Keto-Mycolic Acid-Dependent Pellicle Formation Confers Tolerance to Drug-Sensitive Mycobacterium tuberculosis

机译:酮-霉菌酸依赖性皮膜形成赋予对药物敏感性结核分枝杆菌的耐受性

获取原文

摘要

The chronic nature of tuberculosis (TB), its requirement of long duration of treatment, its ability to evade immune intervention, and its propensity to relapse after drug treatment is discontinued are reminiscent of other chronic, biofilm-associated bacterial diseases. Historically, Mycobacterium tuberculosis was grown as a pellicle, a biofilm-like structure, at the liquid-air interface in a variety of synthetic media. Notably, the most widely administered human vaccine, BCG, is grown as a pellicle for vaccine production. However, the molecular requirements for this growth remain ill defined. Here, we demonstrate that keto-mycolic acids (keto-MA) are essential for pellicle growth, and mutants lacking in or depleted of this MA species are unable to form a pellicle. We investigated the role of the pellicle biofilm in the reduction of antibiotic sensitivity known as drug tolerance using the pellicle-defective ΔmmaA4 mutant strain. We discovered that the ΔmmaA4 mutant, which is both pellicle defective and highly sensitive to rifampicin (RIF) under planktonic growth, when incorporated within the wild-type pellicle biofilm, was protected from the bactericidal activity of RIF. The observation that growth within the M. tuberculosis pellicle biofilm can confer drug tolerance to a drug-hypersensitive strain suggests that identifying molecular requirements for pellicle growth could lead to development of novel interventions against mycobacterial infections. Our findings also suggest that a class of drugs that can disrupt M. tuberculosis biofilm formation, when used in conjunction with conventional antibiotics, has the potential to overcome drug tolerance. >IMPORTANCE Two of the most important questions in tuberculosis (TB) research are (i) how does Mycobacterium tuberculosis persist in the human host for decades in the face of an active immune response and (ii) why does it take six?months and four drugs to treat uncomplicated TB. Both these aspects of M. tuberculosis biology are reminiscent of infections caused by organisms capable of forming biofilms. M. tuberculosis is capable of growing as a biofilm-like structure called the pellicle. In this study, we demonstrate that a specific cell wall component, keto-mycolic acid, is essential for pellicle growth. We also demonstrate that a strain of M. tuberculosis that is both drug sensitive and pellicle defective exhibits commensal behavior and becomes drug tolerant by becoming part of a heterogeneous pellicle, a characteristic of multispecies biofilms. These observations could have important implications for identifying novel pathways for M. tuberculosis drug tolerance and the design of new modalities to rapidly treat TB.
机译:结核病(TB)的慢性性质,长期治疗的要求,逃避免疫干预的能力以及中止药物治疗后复发的倾向,都使人联想到其他与生物膜相关的慢性细菌性疾病。历史上,结核分枝杆菌在各种合成介质中的液-气界面处生长为薄膜状的生物膜状结构。值得注意的是,施用最广泛的人类疫苗BCG作为用于生产疫苗的防护膜而生长。但是,这种生长的分子要求仍然不明确。在这里,我们证明了酮-霉菌酸(keto-MA)对于防护膜的生长是必不可少的,缺少或缺失该MA物种的突变体无法形成防护膜。我们使用防护膜缺陷型Δ mmaA4 突变菌株调查了防护膜生物膜在降低抗生素敏感性(称为耐药性)中的作用。我们发现,结合到野生型防护膜生物膜中的Δ mmaA4 突变体具有防护膜缺陷,并且对浮游生物生长下的利福平(RIF)高度敏感,可以保护其免受RIF的杀菌活性。观察到 M内的增长。结核菌膜生物膜可以赋予药物敏感性较高的菌株以耐药性,这表明识别菌膜生长的分子需求可能会导致开发针对分枝杆菌感染的新干预措施。我们的发现还表明,一类可以破坏M的药物。与常规抗生素结合使用时,结核生物膜的形成具有克服药物耐受性的潜力。 >重要性在结核病(TB)研究中,两个最重要的问题是(i)面对主动的免疫反应,结核分枝杆菌如何在人体内持续数十年(ii)为什么要治疗六个月的时间和四种药物来治疗简单的结核病。 M的这两个方面。结核病生物学使人联想到能够形成生物膜的生物体引起的感染。 M。结核病能够以生物膜状结构(称为薄膜)生长。在这项研究中,我们证明了特定的细胞壁成分,酮-霉菌酸,是薄膜生长必不可少的。我们还证明了 M菌株。药物敏感性和防护膜缺陷的结核病表现出共同的行为,并通过成为多种生物膜特征的异质防护膜的一部分而变得对药物具有耐受性。这些发现可能对确定 M的新途径具有重要意义。结核病的耐药性和快速治疗结核病的新方法的设计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号